Fosun Pharma (stock code 02196), also known as Shanghai Fosun Pharmaceutical Group Co., Ltd., announced on June 26, 2024 that it will distribute year-end ordinary dividends for the year ended December 31, 2023, at RMB 0.27 per share. The dividends will be distributed at a rate of 1 RMB to 0.91208 HKD. Shareholders must submit share transfer documents before July 26, 2024 to qualify for the dividend distribution. The company will suspend share transfer registration procedures on August 5, 2024 and distribute dividends on August 23, 2024. Fosun Pharma's executive directors include Mr. Wu Yifang, Mr. Wang Kexin, Ms. Guan Xiaohui, and Mr. Wen Deyong, while non-executive directors include Mr. Chen Qiyu, Mr. Yao Fang, Mr. Xu Xiaoliang, and Mr. Pan Donghui. Independent non-executive directors include Ms. Li Ling, Mr. Tang Guiliang, Mr. Wang Quandi, and Mr. Yu Zishan.

Fosun Pharma (stock code 02196), also known as Shanghai Fosun Pharmaceutical Group Co., Ltd., announced on June 26, 2024 that it will distribute year-end ordinary dividends for the year ended December 31, 2023, at RMB 0.27 per share. The dividends will be distributed at a rate of 1 RMB to 0.91208 HKD. Shareholders must submit share transfer documents before July 26, 2024 to qualify for the dividend distribution. The company will suspend share transfer registration procedures on August 5, 2024 and distribute dividends on August 23, 2024. Fosun Pharma's executive directors include Mr. Wu Yifang, Mr. Wang Kexin, Ms. Guan Xiaohui, and Mr. Wen Deyong, while non-executive directors include Mr. Chen Qiyu, Mr. Yao Fang, Mr. Xu Xiaoliang, and Mr. Pan Donghui. Independent non-executive directors include Ms. Li Ling, Mr. Tang Guiliang, Mr. Wang Quandi, and Mr. Yu Zishan.